BNKL — Bionik Laboratories Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.447 | 2.27 | 0.608 | 1.99 | 0.427 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.54 | 0.911 | 0.452 | 0.275 | 0.453 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 3.75 | 5.83 | 3.43 | 4.58 | 2.78 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.193 | 0.154 | 0.094 | 0.091 | 0.442 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 30.7 | 18.5 | 8.79 | 4.68 | 3.36 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.27 | 5.2 | 4.1 | 1.49 | 2.31 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.27 | 5.2 | 5.51 | 1.75 | 5 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 27.4 | 13.3 | 3.28 | 2.93 | -1.64 |
Total Liabilities & Shareholders' Equity | 30.7 | 18.5 | 8.79 | 4.68 | 3.36 |
Total Common Shares Outstanding |